Finally, western blotting assay revealed that WWL229 enhanced lipid biosynthesis related gene FABP4 expression and suppressed lipolysis related gene ATGL expression in NSCLC (Figure 3D), indicating that CES3 was an important player in NSCLC lipid metabolism. This evidence concerns the gene CES3 and non-small cell lung carcinoma.